Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dongmei Mu
Silibinin Inhibits Migration and Invasion of the Rhabd Tumor G401 Cell Line via Inactivation of the PI3K/Akt Signaling Pathway
Oncology Letters
Cancer Research
Oncology
Seismotectonics Considered Artificial Neural Network Earthquake Prediction in Northeast Seismic Region of China
Open Civil Engineering Journal
Civil
Structural Engineering
Related publications
Lycorine Inhibits Melanoma A375 Cell Growth and Metastasis Through the Inactivation of the PI3K/AKT Signaling Pathway
Medecine/Sciences
Biochemistry
Medicine
Genetics
Molecular Biology
Overexpression of RASD1 Inhibits Glioma Cell Migration/Invasion and Inactivates the AKT/mTOR Signaling Pathway
Scientific Reports
Multidisciplinary
Correction: CLCA4 Inhibits Bladder Cancer Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/AKT Pathway
Oncotarget
Oncology
Telmisartan Inhibits NSCLC A549 Cell Proliferation and Migration by Regulating the PI3K/AKT Signaling Pathway
Oncology Letters
Cancer Research
Oncology
Downregulated microRNA-30b-3p Inhibits Proliferation, Invasion and Migration of Glioma Cells via Inactivation of the AKT Signaling Pathway by Upregulating RECK
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
MKRN2 Inhibits Migration and Invasion of Non-Small-Cell Lung Cancer by Negatively Regulating the PI3K/Akt Pathway
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Diosgenin Inhibits Cell Proliferation of Primary Human Thyrocytes via Downregulation of PI3K/Akt Signaling Pathway
Tropical Journal of Pharmaceutical Research
Pharmacology
Pharmaceutical Science
IL-17A Promotes Cell Migration and Invasion of Glioblastoma Cells via Activation of PI3K/AKT Signalling Pathway
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway
Chinese Medicine
